DESTINY-Lung01 Trial Investigators 2022, ' Trastuzumab deruxtecan in HER2-mutant non–small-cell lung cancer ', New England Journal of Medicine, vol. 386, no. 3, pp. 241-251 . https://doi.org/10.1056/NEJMoa2112431 N Engl J Med New England Journal of Medicine. MASSACHUSETTS MEDICAL SOC New England Journal of Medicine The New England journal of medicine, vol 386, iss 3 New England Journal of Medicine, 386(3), 241-251. Massachussetts Medical Society